Herbst, Z.; Turgeon, C.T.; Biski, C.; Khaledi, H.; Shoemaker, N.B.; DeArmond, P.D.; Smith, S.; Orsini, J.; Matern, D.; Gelb, M.H.
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease. Int. J. Neonatal Screen. 2020, 6, 29.
https://doi.org/10.3390/ijns6020029
AMA Style
Herbst Z, Turgeon CT, Biski C, Khaledi H, Shoemaker NB, DeArmond PD, Smith S, Orsini J, Matern D, Gelb MH.
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease. International Journal of Neonatal Screening. 2020; 6(2):29.
https://doi.org/10.3390/ijns6020029
Chicago/Turabian Style
Herbst, Zackary, Coleman T. Turgeon, Chad Biski, Hamid Khaledi, Nancy B. Shoemaker, Patrick D. DeArmond, Sara Smith, Joseph Orsini, Dietrich Matern, and Michael H. Gelb.
2020. "Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease" International Journal of Neonatal Screening 6, no. 2: 29.
https://doi.org/10.3390/ijns6020029
APA Style
Herbst, Z., Turgeon, C. T., Biski, C., Khaledi, H., Shoemaker, N. B., DeArmond, P. D., Smith, S., Orsini, J., Matern, D., & Gelb, M. H.
(2020). Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease. International Journal of Neonatal Screening, 6(2), 29.
https://doi.org/10.3390/ijns6020029
